ストックスクリーナーアプリを入手
7.45
1.22%
0.09
プレマーケット:
7.44
-0.010
-0.13%
Ginkgo Bioworks Holdings Inc (DNA) 最新ニュース
Ginkgo Bioworks Holdings Inc (DNA) Balance Sheet - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DNA|Ginkgo Bioworks Holdings Inc|Price:7.445|Chg%:+0.085 - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Income Statement - TradingKey
DNA|Ginkgo Bioworks Holdings Inc|Price:7.761| - TradingKey
ETFs Investing in Ginkgo Bioworks Holdings, Inc. Class A Stocks - TradingView
Ginkgo Bioworks Holdings Inc (DNA) Cash Flow - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DNA|Ginkgo Bioworks Holdings Inc|Price:7.360|Chg%:-0.575 - TradingKey
Responsive Playbooks and the DNA Inflection - Stock Traders Daily
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requiremen - GuruFocus
Ginkgo Bioworks Holdings Inc (DNA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ginkgo CEO Jason Kelly: Block U.S. Investment in Chinese Biotech Before Drug Discovery Moves Entirely Offshore - finance.biggo.com
Biotech firm Ginkgo in talks with SPAC for over $20b deal - The Financial Express
Ginkgo Bioworks (NYSE: DNA) CFO logs RSU vesting and tax sell-to-cover - Stock Titan
Ginkgo Bioworks (DNA) 10K Form and Latest SEC Filings 2026 - MarketBeat
Form 144 Ginkgo Bioworks Holdings For: 17 July By Investing.com - Investing.com Nigeria
Ginkgo Bioworks (NYSE: DNA) insider Steve Coen plans Class A stock sale - Stock Titan
Ginkgo Bioworks (DNA) Slides 7.89% as Market Sentiment Turns CautiousTriple EMA - dars.gov.et
Synthetic Biology Market Set for Strong Expansion | Ginkgo - openPR.com
Ginkgo Bioworks Holdings' Stock Sinks To US$9.07, But Insiders Sold Even Lower - simplywall.st
Ginkgo Bioworks : Q1 2026 Results Presentation - marketscreener.com
DNAGinkgo Bioworks Holdings Inc Options - Finviz
Ginkgo Bioworks reports Q1 revenue decline, reaffirms cash burn - Investing.com
Most Volatile Stocks in the US (July 2026) - Investing.com
Ginkgo Bioworks Holdings Inc Warrant 2021-01.08.26 on Ginkgo Bioworks -A Financial Disclosures & SEC Filings - TradingView
How Western Biotechs Are Navigating The China Challenge - insights.citeline.com
Understanding the Setup: (DNA) and Scalable Risk - Stock Traders Daily
Ginkgo Bioworks (DNA) Holds Near $10.21 as Stock Consolidates in Tight RangeIron Condor Alert - dars.gov.et
Ginkgo Bioworks Holdings, Inc.(NYSE:DNA) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Ginkgo Bioworks Holdings, Inc.(NYSE: DNA) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Ginkgo Bioworks Holdings, Inc.(NYSE:DNA) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Palantir's Bold Biosecurity Opportunity Could Be Bigger Than Investors Think - The Motley Fool
Ginkgo Bioworks (DNA) Q1 2026 Earnings: EPS Misses Estimates, Stock Surges Over 7%Buyback Announcement Report - dars.gov.et
Enterprise value to revenue forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView
Price to earnings forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView
Enterprise value to EBIT forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView
Enterprise value to EBITDA forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView
Price to sales forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView
Ginkgo Bioworks (DNA) Rallies 6.27% as Biotech Sector Shows Renewed StrengthInitial Balance - dars.gov.et
Ginkgo Bioworks Holdings, Inc. Class A Actuals & Estimates (NYSE:DNA) - TradingView
9L40 Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Price to earnings forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Enterprise value to EBITDA forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Price to book forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
DNA Forecast — Price Target — Prediction for 2027 - TradingView
Ginkgo Bioworks Holdings Inc (DNA) Valuation: PE, PB & Fair Value Analysis - TradingKey
The Technical Signals Behind (DNA) That Institutions Follow - Stock Traders Daily
DNA Technical Analysis & Stock Price Forecast - Intellectia AI
Ginkgo Bioworks Holdings Inc (DNA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Institutional Confidence - TradingKey
Ginkgo Bioworks Holdings Inc - TradingKey
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):